(Q44555042)

4 December 2017

title

Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy (English)

1 reference

4 December 2017

1

1 reference

4 December 2017

8

1 reference

4 December 2017

Costantino Di Carlo

2

1 reference

4 December 2017

Michele Morelli

3

1 reference

4 December 2017

Tiziana Russo

4

1 reference

4 December 2017

Roberto Noia

5

1 reference

4 December 2017

Carmine Nappi

6

1 reference

4 December 2017

Pasquale Mastrantonio

7

1 reference

4 December 2017

publication date

1 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

45

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

267-273

1 reference

Hormone replacement therapy (HRT)--risks and benefits

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

The adverse effects of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Consequences of long-term hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Hormone replacement therapy and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Hormone replacement therapy and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Tibolone and climacteric symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Changes in sex behaviour after menopause: effects of tibolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Clinical experience with tibolone (Livial) over 8 years

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Breast cancer diagnosed during hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

A pilot study of hormone replacement therapy with tibolone in women with mastopathic breasts

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Effects of different types of hormone replacement therapy on mammographic density

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Mammographic density changes during different postmenopausal hormone replacement therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Hormone replacement therapy and accuracy of mammographic screening

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Effects of tibolone on the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Tibolone: a compound with tissue specific inhibitory effects on sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Tibolone: a steroid with a tissue-specific mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Tibolone actions on normal and breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

The selective estrogen enzyme modulator (SEEM) in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Inhibition of oestrone sulphatase activity by tibolone and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

Tibolone: what does tissue specific activity mean?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2803%2900153-1

7 January 2021

10.1016/S0378-5122(03)00153-1

Identifiers

DOI

1 reference

4 December 2017

1 reference